(Q44385440)

2 December 2017

title

Development of a prostate-specific promoter for gene therapy against androgen-independent prostate cancer (English)

1 reference

2 December 2017

0 references

Souichi Furuhata

1

1 reference

2 December 2017

Hisamitsu Ide

2

1 reference

2 December 2017

Yoshiaki Miura

3

1 reference

2 December 2017

Teruhiko Yoshida

4

1 reference

2 December 2017

Kazunori Aoki

5

1 reference

2 December 2017

publication date

1 March 2003

1 reference

2 December 2017

1 reference

2 December 2017

volume

7

1 reference

2 December 2017

issue

3

1 reference

2 December 2017

page(s)

366-374

1 reference

2 December 2017

cites work

Cancer statistics, 1999.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900059-X

7 January 2021

In vivo amplification of the androgen receptor gene and progression of human prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900059-X

7 January 2021

A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900059-X

7 January 2021

Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900059-X

7 January 2021

Immunohistochemical study of androgen receptors in metastatic prostate cancer. Comparison of receptor content and response to hormonal therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900059-X

7 January 2021

Targeting and eradicating cancer cells by a prostate-specific vector carrying the diphtheria toxin A gene

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900059-X

7 January 2021

Relative activity and specificity of promoters from prostate-expressed genes

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900059-X

7 January 2021

In vivo gene therapy for prostate cancer: preclinical evaluation of two different enzyme-directed prodrug therapy systems delivered by identical adenovirus vectors

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900059-X

7 January 2021

Transcription-targeted gene therapy for androgen-independent prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900059-X

7 January 2021

Gene regulation by steroid hormones

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900059-X

7 January 2021

Novel therapeutic approach: organic arsenical melarsoprol) alone or with all-trans-retinoic acid markedly inhibit growth of human breast and prostate cancer cells in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900059-X

7 January 2021

Retinoids: present role and future potential

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900059-X

7 January 2021

Polyethylenimine-mediated gene transfer into pancreatic tumor dissemination in the murine peritoneal cavity

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900059-X

7 January 2021

Restricted expression of an adenoviral vector encoding Fas ligand (CD95L) enhances safety for cancer gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900059-X

7 January 2021

Androgen receptor expression in androgen-independent prostate cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900059-X

7 January 2021

Differential expression of nuclear retinoid receptors in normal and malignant prostates

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900059-X

7 January 2021

Phase I clinical trial of all-trans-retinoic acid with correlation of its pharmacokinetics and pharmacodynamics

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900059-X

7 January 2021

Prostate cancer gene therapy: herpes simplex virus thymidine kinase gene transduction followed by ganciclovir in mouse and human prostate cancer models

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900059-X

7 January 2021

Cooperative therapeutic effects of androgen ablation and adenovirus-mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy in experimental prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900059-X

7 January 2021

Prostate-specific targeting using PSA promoter-based lentiviral vectors

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900059-X

7 January 2021

Localization of prostatic basic protein ("probasin") in the rat prostates by use of monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900059-X

7 January 2021

Expression of retinoic acid receptor-beta sensitizes prostate cancer cells to growth inhibition mediated by combinations of retinoids and a 19-nor hexafluoride vitamin D3 analog

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900059-X

7 January 2021

Gene therapy death prompts review of adenovirus vector

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900059-X

7 January 2021

10.1016/S1525-0016(02)00059-X

Identifiers

DOI

1 reference

2 December 2017

1 reference